Evobrutinib

1415823-73-2

M-2951, MSC-2364447C

C13662-5mg

BTK

Protein Tyrosine Kinase

C=CC (=O) N1CCC (CC1) CNC2=NC=NC (=C2C3=CC=C (C=C3) OC4=CC=CC=C4) N

C25H27N5O2

Evobrutinib is a highly selective BTK inhibitor with an IC50 of 37.9 nM. It has potential anti-neoplastic activity.

3 years -20°C powder